Larimar Therapeutics, Inc. (LRMR) Institutional Ownership & Insider Trading
162 institutions reported holding Larimar Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 8 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
LRMRLarimar Therapeutics, Inc.Follow LRMR — free
—
Price chart with a free account
- Market cap
- 244.1M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters162 institutions held 91.9% of the shares. Across filers that reported both quarters, shares held changed +8.9%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 162 | 95 | +8.9% | 65 | 31 | 39 | 25 |
| Mar 26 | 162 | 88 | +24.6% | 56 | 37 | 40 | 13 |
| Dec 25 | 134 | 72 | -14.4% | 44 | 21 | 42 | 18 |
| Sep 25 | 134 | 86 | +37.1% | 57 | 26 | 25 | 9 |
| Jun 25 | 116 | 62 | +2.5% | 41 | 30 | 21 | 16 |
| Mar 25 | 103 | 61 | -3.8% | 30 | 15 | 30 | 27 |
| Dec 24 | 115 | 63 | -1.8% | 41 | 14 | 29 | 25 |
| Sep 24 | 123 | 64 | -2.0% | 34 | 22 | 33 | 7 |
Larimar Therapeutics, Inc. — questions
- Who owns Larimar Therapeutics, Inc. stock?
- 162 institutions reported Larimar Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: DEERFIELD MANAGEMENT COMPANY, L.P. (34.3%), Blue Owl Capital Holdings LP (8.8%), BlackRock, Inc. (5.5%).
- Are Larimar Therapeutics, Inc. insiders buying or selling?
- 8 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from Larimar Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.